CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge

The COVID-19 pandemic presents an unprecedented challenge to global public health. Rapid development and deployment of safe and effective vaccines are imperative to control the pandemic. In the current study, we applied our adjuvanted stable prefusion SARS-CoV-2 spike (S-2P)-based vaccine, MVC-COV19...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Lien, Chia-En, Lin, Yi-Jiun, Chen, Charles, Lian, Wei-Cheng, Kuo, Tsun-Yung, Campbell, John D., Traquina, Paula, Lin, Meei-Yun, Liu, Luke Tzu-Chi, Chuang, Ya-Shan, Ko, Hui-Ying, Liao, Chun-Che, Chen, Yen-Hui, Jan, Jia-Tsrong, Ma, Hsiu-Hua, Sun, Cheng-Pu, Lin, Yin-Shiou, Wu, Ping-Yi, Wang, Yu-Chiuan, Tao, Mi-Hua, Lin, Yi-Ling
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8062487/
https://ncbi.nlm.nih.gov/pubmed/33888840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-88283-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi